OREX
TD Asset Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-293,400
| Closed | -$505K | – | 1422 |
|
|
2015
Q4 | $505K | Sell |
293,400
-2,200
| -0.7% | -$3.79K | ﹤0.01% | 1099 |
|
|
2015
Q3 | $624K | Buy |
295,600
+4,300
| +1% | +$9.08K | ﹤0.01% | 1027 |
|
|
2015
Q2 | $1.44M | Sell |
291,300
-14,800
| -5% | -$73.3K | ﹤0.01% | 904 |
|
|
2015
Q1 | $2.4M | Buy |
306,100
+32,000
| +12% | +$251K | ﹤0.01% | 811 |
|
|
2014
Q4 | $1.66M | Sell |
274,100
-21,800
| -7% | -$132K | ﹤0.01% | 860 |
|
|
2014
Q3 | $1.26M | Buy |
295,900
+106,500
| +56% | +$454K | ﹤0.01% | 873 |
|
|
2014
Q2 | $1.17M | Buy |
189,400
+95,800
| +102% | +$592K | ﹤0.01% | 883 |
|
|
2014
Q1 | $608K | Buy |
+93,600
| New | +$608K | ﹤0.01% | 988 |
|
|
2013
Q3 | – | Sell |
-29,900
| Closed | -$175K | – | 1303 |
|
|
2013
Q2 | $175K | Buy |
+29,900
| New | +$175K | ﹤0.01% | 1144 |
|